A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved ... tenofovir alafenamide and integrase inhibitor bictegravir. ViiV claimed the latter compound infringes its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback